Orpea SA
OTC:ORPEF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (20.6), the stock would be worth $-4.28 (130% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -68.2 | $14.22 |
0%
|
| Industry Average | 20.6 | $-4.28 |
-130%
|
| Country Average | 13.2 | $-2.76 |
-119%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
$8.2B
|
/ |
Jan 2024
€-120.7m
|
= |
|
|
$8.2B
|
/ |
Dec 2024
€28.3m
|
= |
|
|
$8.2B
|
/ |
Dec 2025
€224.2m
|
= |
|
|
$8.2B
|
/ |
Dec 2026
€344.4m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| FR |
|
Orpea SA
OTC:ORPEF
|
772.3m USD | -68.2 | 0.6 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
107.6B USD | 12.2 | 15.9 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 40 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
24B ZAR | 9.5 | 14.3 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.2B MYR | 22.6 | 36.8 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
18B ZAR | -53.4 | 4.7 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
87B BRL | 9.4 | 18.6 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
16.6B USD | 7.1 | 11.8 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
90.4B CNY | 20 | 28.1 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 42.9 | 61.3 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.8B USD | 24.1 | 31.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 9.5 |
| Median | 13.2 |
| 70th Percentile | 17.5 |
| Max | 1 862.3 |
Other Multiples
Orpea SA
Glance View
Orpea SA, founded in 1989, has established itself as one of Europe's leading providers of long-term care. Operating within the healthcare sector, Orpea's business model is centered around a wide network of nursing homes, rehabilitation centers, and psychiatric care facilities across numerous countries. The company seeks to address the needs of an aging population, which has driven demand for high-quality, personalized care services. Leveraging both organic growth and strategic acquisitions, Orpea has expanded its footprint, focusing on maintaining a comprehensive care model that caters to varying health requirements. This has included making significant investments in modern facilities designed to enhance the quality of life for their residents, thereby emphasizing both medical care and comfort. Orpea's revenue streams primarily stem from the fees it charges for its residential and healthcare services, with a robust emphasis on operational efficiency and facility management to ensure profitability. The company's growth strategy isn't just focused on expanding its geographical presence but also on enhancing the quality of its offerings to appeal to a clientele that demands excellent care. This model has allowed Orpea to scale effectively while maintaining a high standard of service, which is pivotal in an industry where trust and reputation are paramount. However, maintaining such extensive operations also means navigating complex regulatory landscapes and ensuring compliance, presenting both challenges and opportunities for enhancing governance and care excellence.